[Application of pre- and post-transfusion virological controls prior to the suppression of their recommendation].
In 1996, due to a residual risk of transfusion-transmitted virus, a circular of the French Health Authorities (DGS/DH n degrees 96-609) recommended proposing to recipients of cellular blood products a test for antibodies to human immunodeficiency virus (HIV) and for antibodies to hepatitis C virus, before and three months after transfusion. We have evaluated the application of this recommendation throughout the whole transfused population of a French Hospital over a three month period. In addition, this study allowed us to establish the vaccination status against hepatitis B virus (HBV) infection in this exposed population including transfusion and nosocomial risks. The results showed a failure in the application of the 1996 circular and confirmed the validity of the abrogation of this circular by a recent circular (11 January 2006) of the French health authorities. It also showed that only a minority of patients needing a vaccination against HBV were afforded such treatment during their hospitalization.
Petit
H
H
Laboratoire d'hématologie, CHU d'Amiens, place Victor-Pauchet, 80054 Amiens, France.
Laperche
S
S
Lefrère
J-J
JJ
D001803:Blood Transfusion / Q000592:standards*; D005602:France / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D018570:Risk Assessment; D014777:Virus Diseases / Q000517:prevention & control* / Q000635:transmission